Market Snapshot

BSE Sensex: 78472.87 -0.09%
BSE 500: 35222.65 -0.02%
BSE 200: 10956.33 -0.09%
BSE 100: 25137.89 -0.08%
BSE MidCap: 46314.02 0.09%
BSE SmallCap: 55023.17 0.37%
BSE BANKEX: 58198.35 -0.22%
BSE IT: 43507.76 -0.28%
Nifty 50: 23727.65 -0.11%
Nifty 500: 22402.7 -0.04%
Nifty 200: 13436 -0.10%
Nifty 100: 24572.5 -0.11%
Nifty Midcap 100: 57057.9 -0.06%
Nifty Small 100: 18732.65 0.24%
Nifty IT: 43668.9 -0.36%
Nifty PSU Bank: 6609.55 -0.56%

News:

Aarti Drugs sizzles after Tara...
Biocon jumps as Bengaluru unit...
Interarch Building soars on st...
Kwality Pharma gains on securi...
Hindustan Construction Company...

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

24 Dec 2024 | 04:14 PM

636.65

-9.80 (-1.52%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

63.37%

Return (1Y)

Beaten Nifty 50 by 52.59%
More Volatile

3.43%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.54%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

820

274

News & Announcements

Jagsonpal Pharmaceuticals fixes record date for stock split
6 days ago

Jagsonpal Pharmaceuticals fixes record date for stock split

18 - Dec - 2024 12:00 AM | 6 days ago

Jagsonpal Pharmaceuticals has fixed 08 January 2025 as record date for stock split of the Company such that 1 (one) equity share having face value of Rs. 5/- (Rupees five only) each, fully paid-up, be sub-divided into such number of equity shares having face value of Rs. 2 (Rupee two only) each, fully paid up.
Powered by Capital Market - Live News
Jagsonpal Pharmaceuticals allots 31,040 equity shares under ESOP
18 days ago

Jagsonpal Pharmaceuticals allots 31,040 equity shares under ESOP

06 - Dec - 2024 12:00 AM | 18 days ago

Jagsonpal Pharmaceuticals has allotted 31,040 equity shares under ESOP. Consequently, the paid up equity share capital has increased to Rs. 13,27,29,810 (constituting of 2,65,45,962 equity shares of Rs. 5/- each).
Powered by Capital Market - Live News
Jagsonpal Pharmaceuticals standalone net profit rises 53.41% in the September 2024 quarter
61 days ago

Jagsonpal Pharmaceuticals standalone net profit rises 53.41% in the September 2024 quarter

24 - Oct - 2024 12:00 AM | 61 days ago

Net profit of Jagsonpal Pharmaceuticals rose 53.41% to Rs 11.46 crore in the quarter ended September 2024 as against Rs 7.47 crore during the previous quarter ended September 2023. Sales rose 29.15% to Rs 74.69 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023.
Particulars Quarter Ended
Sep. 2024 Sep. 2023 % Var.
Sales 74.69 57.83 29
OPM % 21.81 14.47 -
PBDT 17.71 10.42 70
PBT 15.37 9.96 54
NP 11.46 7.47 53
Powered by Capital Market - Live News
Jagsonpal Pharmaceuticals to table results
68 days ago

Jagsonpal Pharmaceuticals to table results

17 - Oct - 2024 12:00 AM | 68 days ago

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October 2024.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Jagsonpal Pharmaceuticals Ltd has increased by 107.72% since past 3 Months
MF shareholding in Jagsonpal Pharmaceuticals Ltd has increased by 27800% since past 3 Months
FII shareholding in Jagsonpal Pharmaceuticals Ltd has increased by 505.73% since past 1 Year
MF shareholding in Jagsonpal Pharmaceuticals Ltd has increased by 37100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	74.69	57.83	29
OPM %	21.81	14.47	-
PBDT	17.71	10.42	70
PBT	15.37	9.96	54
NP	11.46	7.47	53

General Notifications

My Notifications

Research Notifications

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

636.65 -9.80 (-1.52%)

News & Announcements

Price vs Volume

Stock Trivia

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

636.65

-9.80 (-1.52%)